Glazer Capital's Ownership in scPharmaceuticals Inc.


2025-09-10SEC Filing SCHEDULE 13G (0001076809-25-000106)

Glazer Capital, LLC and Paul J. Glazer have filed a Schedule 13G indicating their ownership in scPharmaceuticals Inc. As of the filing date, Glazer Capital and Paul J. Glazer collectively own 2,474,820 shares of common stock, representing 4.64% of the outstanding shares. The filing states that the shares are held by certain funds and managed accounts for which Glazer Capital serves as investment manager. The filing also notes that the Reporting Persons may have previously owned more than 5% of the outstanding shares but have since reduced their ownership below this threshold. The filing is made under Rule 13d-1(c) and includes certifications that the shares were not acquired for the purpose of influencing the control of the issuer.


Tickers mentioned in this filing:SCPH